Cargando…

ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancer due to its highly aggressive phenotype and lack of effective biomarkers or treatment strategies. ZMAT1 belongs to the C2H2 type zinc finger family, but its biological function is rarely investigated, as well as its ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zuyi, Li, Zhenchong, Wang, Shujie, Zhou, Zixuan, Liu, Chunsheng, Zhuang, Hongkai, Zhou, Qi, Huang, Shanzhou, Zhang, Chuanzhao, Hou, Baohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988381/ https://www.ncbi.nlm.nih.gov/pubmed/35392973 http://dx.doi.org/10.1186/s13046-022-02310-8

Ejemplares similares

Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy
por: Zhuang, Hongkai, et al.
Publicado: (2021)

Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas
por: Zhuang, Hongkai, et al.
Publicado: (2021)

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer
por: Zhou, Zixuan, et al.
Publicado: (2021)

Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer
por: Li, Zhenchong, et al.
Publicado: (2022)

Identification of MBOAT2 as an Unfavorable Biomarker Correlated with KRAS Activation and Reduced CD8(+) T-Cell Infiltration in Pancreatic Cancer
por: Li, Zhenchong, et al.
Publicado: (2022)

A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma
por: Wu, Zelong, et al.
Publicado: (2023)

A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience
por: Ma, Zuyi, et al.
Publicado: (2021)

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer
por: Ma, Zuyi, et al.
Publicado: (2021)

Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
por: Zhuang, Hongkai, et al.
Publicado: (2020)

B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8(+) T cells in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Prognostic values and immune suppression of the S100A family in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2021)

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma
por: Huang, Shanzhou, et al.
Publicado: (2022)

Incidental intraoperative finding of gallbladder duplication in a patient with a choledochal cyst
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma
por: Huang, Shanzhou, et al.
Publicado: (2020)

Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Zmat2 in mammals: conservation and diversification among genes and Pseudogenes
por: Rotwein, Peter, et al.
Publicado: (2020)

GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8(+) T cells infiltration in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
por: Best, Sarah A., et al.
Publicado: (2020)

ZMAT2 in Humans and Other Primates: A Highly Conserved and Understudied Gene
por: Baral, Kabita, et al.
Publicado: (2020)

Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma
por: XUE, ZHANXIONG, et al.
Publicado: (2016)

Protein salvador homolog 1 acts as a tumor suppressor and is modulated by hypermethylation in pancreatic ductal adenocarcinoma
por: Wang, Lei, et al.
Publicado: (2017)

Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2023)

The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma
por: Muys, Bruna R., et al.
Publicado: (2021)

MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor
por: Chen, Yan, et al.
Publicado: (2019)

A Maize ZmAT6 Gene Confers Aluminum Tolerance via Reactive Oxygen Species Scavenging
por: Du, Hanmei, et al.
Publicado: (2020)

The Zmat2 gene in non-mammalian vertebrates: Organizational simplicity within a divergent locus in fish
por: Rotwein, Peter
Publicado: (2020)

High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
por: Stenzinger, Albrecht, et al.
Publicado: (2013)

Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma
por: Mardin, Wolf Arif, et al.
Publicado: (2013)

ZMAT3 hypomethylation contributes to early senescence of preadipocytes from healthy first‐degree relatives of type 2 diabetics
por: Spinelli, Rosa, et al.
Publicado: (2022)

Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice
por: Ghosh, Shrestha, et al.
Publicado: (2018)

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma
por: Evers, Lisa, et al.
Publicado: (2014)

WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
por: Yin, Wenke, et al.
Publicado: (2023)

Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection
por: Zhang, Chuanzhao, et al.
Publicado: (2019)

Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
por: Li, Qing, et al.
Publicado: (2016)

SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion
por: Sun, Hongjie, et al.
Publicado: (2018)

BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma
por: Gao, Yushun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9gm0r34abt358ticse9ga1ni2n